乳腺癌前哨淋巴结规范化处理

邱鹏飞; 王永胜

doi:10.12354/j.issn.1000-8179.2022.20221120

乳腺癌前哨淋巴结规范化处理

doi: 10.12354/j.issn.1000-8179.2022.20221120

邱鹏飞,
王永胜^,

山东省肿瘤防治研究院（山东省肿瘤医院）乳腺外科，山东第一医科大学（山东省医学科学院)(济南市 250117）

基金项目: 本文课题受国家自然科学基金项目（编号：82172873）、山东省自然科学基金项目（编号：ZR2021QH002）和中国博士后科学基金项目（编号：2021M691334）资助

详细信息

作者简介:
邱鹏飞：专业方向为乳腺肿瘤临床与基础研究

通讯作者:
王永胜　wangysh2008@aliyun.com

计量
- 文章访问数: 182
- HTML全文浏览量: 36
- PDF下载量: 73
- 被引次数: 0
出版历程
- 收稿日期: 2022-07-30
- 录用日期: 2022-09-13
- 修回日期: 2022-09-07

Standardized management of sentinel lymph nodes in breast cancer

Pengfei Qiu,
Yongsheng Wang^,

Department of Breast Surgery, Shandong Cancer Hospital and Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China

More Information

Corresponding author: Yongsheng Wang; E-mail: wangysh2008@aliyun.com

摘要

摘要: 前哨淋巴结活检术（sentinel lymph node biopsy, SLNB）标志着乳腺癌淋巴结手术进入微创时代，循证医学I类证据支持SLNB是临床腋窝淋巴结阴性早期乳腺癌患者安全、有效的腋窝诊断技术，前哨淋巴结阴性及低肿瘤负荷患者行SLNB替代腋窝淋巴结清扫术后，腋窝淋巴结复发风险和并发症极低。作为乳腺癌区域淋巴结微创诊断技术，SLNB安全有效替代腋窝淋巴结清扫术应建立在规范化操作前提下。目前SLNB在我国早期乳腺癌患者中逐渐趋于规范化和普及化，本文将对临床实践中SLNB的适应证、示踪剂应用、学习曲线掌握、手术规范操作和组织标本处理等问题进行综述。
- 乳腺癌 /
- 前哨淋巴结活检 /
- 腋窝淋巴结 /
- 规范化操作
Abstract: The minimally invasive era for lymph node surgery in breast cancer began with sentinel lymph node biopsy (SLNB). Evidence-based medicine class I evidence supports that SLNB is a safe and effective axillary staging technique for patients with clinically negative axillary lymph node early breast cancer. The risk of axillary lymph node metastasis and complications in breast cancer patients with negative/low tumor burden sentinel lymph nodes without axillary lymph node dissection is very low. As a minimally invasive staging technique for breast cancer regional lymph nodes, SLNB should be established as a standardized operation for safe and effective replacement of axillary lymph node dissection. At present, SLNB has gradually become standardized and popularized for early breast cancer patients in China. This article reviews the SLNB indications, tracer application, learning curve, standard operation and tissue management.
- breast cancer /
- sentinel lymph node biopsy (SLNB) /
- axillary lymph node /
- standardized management

HTML全文

参考文献(20)

[1]	Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe[J]. Surg Oncol, 1993, 2(6):335-339. doi: 10.1016/0960-7404(93)90064-6
[2]	Brackstone M, Baldassarre FG, Perera FE, et al. Management of the axilla in early-stage breast cancer: Ontario health (cancer care Ontario) and ASCO guideline[J]. J Clin Oncol, 2021, 39(27):3056-3082. doi: 10.1200/JCO.21.00934
[3]	中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2021年版)[J].中国癌症杂志,2021,31(10):954-1040. doi: 10.19401/j.cnki.1007-3639.2021.10.013
[4]	郭瑢,李伦,张琪,等.中国乳腺癌前哨淋巴结活检现状调查研究[J].中国癌症杂志,2020,30(3):166-173. doi: 10.19401/j.cnki.1007-3639.2020.03.002
[5]	Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial[J]. Lancet Oncol, 2010, 11(10):927-933. doi: 10.1016/S1470-2045(10)70207-2
[6]	Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer[J]. N Engl J Med, 2003, 349(6):546-553. doi: 10.1056/NEJMoa012782
[7]	Galimberti V, Cole BF, Viale G, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial[J]. Lancet Oncol, 2018, 19(10):1385-1393. doi: 10.1016/S1470-2045(18)30380-2
[8]	Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial[J]. JAMA, 2017, 318(10):918-926. doi: 10.1001/jama.2017.11470
[9]	Simons JM, van Nijnatten TJA, van der Pol CC, et al. Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and Meta-analysis[J]. Ann Surg, 2019, 269(3):432-442. doi: 10.1097/SLA.0000000000003075
[10]	邵志敏,沈镇宙.乳腺原位癌[M].上海:复旦大学出版社,2017.
[11]	Barrio AV, Montagna G, Mamtani A, et al. Nodal recurrence in patients with node-positive breast cancer treated with sentinel node biopsy alone after neoadjuvant chemotherapy-a rare event[J]. JAMA Oncol, 2021, 7(12):1851-1855. doi: 10.1001/jamaoncol.2021.4394
[12]	Kahler-Ribeiro-Fontana S, Pagan E, Magnoni F, et al. Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up[J]. Eur J Surg Oncol, 2021, 47(4):804-812. doi: 10.1016/j.ejso.2020.10.014
[13]	Poodt IGM, Vugts G, Maaskant-Braat AJG, et al. Risk of regional recurrence after negative repeat sentinel lymph node biopsy in patients with ipsilateral breast tumor recurrence[J]. Ann Surg Oncol, 2018, 25(5):1312-1321. doi: 10.1245/s10434-018-6384-y
[14]	Poodt IGM, Vugts G, Schipper RJ, et al. Repeat sentinel lymph node biopsy for ipsilateral breast tumor recurrence: a systematic review of the results and impact on prognosis[J]. Ann Surg Oncol, 2018, 25(5):1329-1339. doi: 10.1245/s10434-018-6358-0
[15]	Wang CB, Tong FZ, Cao YM, et al. Long-term follow-up results of fluorescence and blue dye guided sentinel lymph node biopsy in early breast cancer[J]. Breast Cancer Res Treat, 2021, 188(2):361-368.
[16]	Zhou PP, Zheng WZ, Liu YB, et al. Preoperative contrast-enhanced ultrasound (CEUS) combined with ¹²⁵I seeds localization in sentinel lymph node biopsy for breast cancer[J]. Cancer Manag Res, 2021, 13:1853-1860. doi: 10.2147/CMAR.S296142
[17]	Chagpar A, Martin RC 3rd, Chao CL, et al. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy[J]. Arch Surg, 2004, 139(6):614-618. doi: 10.1001/archsurg.139.6.614
[18]	毕钊,邱鹏飞,王永胜.乳腺癌内乳区淋巴结诊疗的研究进展[J].中国肿瘤临床,2017,44(21):1104-1107. doi: 10.3969/j.issn.1000-8179.2017.21.641
[19]	Qiu PF, Zhao RR, Wang W, et al. Internal mammary sentinel lymph node biopsy in clinically axillary lymph node-positive breast cancer: diagnosis and implications for patient management[J]. Ann Surg Oncol, 2020, 27(2):375-383. doi: 10.1245/s10434-019-07705-0
[20]	Liu LC, Lang JE, Lu Y, et al. Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients: a meta-analysis and single-institution experience[J]. Cancer, 2011, 117(2):250-258. doi: 10.1002/cncr.25606